Q87.8 Q63.9 N04
Conditions
Interventions
Group 1: After information, informed consent and inclusion, an additional 1-3 ml of EDTA blood will be collected as part of a study-independent, clinically indicated blood sample. The procedure is the
Sponsors
Institut für Humangenetik, LMU Klinikum
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Suspicion of hereditary disease of the kidneys and/or urinary tract
Exclusion criteria
Exclusion criteria: Missing consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Molecular evidence of disease-causing variants compatible with the clinical phenotype | — |
Secondary
| Measure | Time frame |
|---|---|
| Sequencing of coding and non-coding regions in the genome to identify further causes of kidney disease | — |
Countries
Germany
Contacts
Public ContactJulia Höfele
Institut für Humangenetik, LMU Klinikum
Outcome results
None listed